(Press-News.org) Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s Disease. The findings also support less studied pathways involved in the pathogenesis of the disease.
The study, published today in npj Parkinson‘s Disease, used whole-genome sequence data from Iceland (deCODE genetics), the UK (UK Biobank), and the US (Accelerating Medicines Partnership Parkinson‘s disease).
The role of ITSN1, Intersectin-1, is to activate CDC42, a small Rho GTPase involved in the growth and maintenance of dopaminergic neurons and the regulation of vesicle exocytosis of α-synuclein, whose accumulation is a pathological hallmark of Parkinson‘s Disease. The researchers propose that loss of ITSN1 function may contribute to Parkinson‘s Disease pathogenesis through inactive CDC42 and its downstream pathways, degeneration of dopaminergic neurons and dysregulated vesicle exocytosis of α-synuclein, and/or through disrupted synaptic vesicle transport via clathrin-mediated endo- and exocytosis. This suggests that targeting CDC42 or its upstream regulator, ITSN1, might offer a therapeutic approach for Parkinson's Disease.
END
deCODE genetics: Rare sequence variants, that associate with a high risk of Parkinson‘s Disease
2024-08-15
ELSE PRESS RELEASES FROM THIS DATE:
Cleaning up the aging brain: Scientists restore brain's trash disposal system
2024-08-15
Alzheimer’s, Parkinson’s, and other neurological disorders can be seen as “dirty brain” diseases, where the brain struggles to clear out harmful waste. Aging is a key risk factor because, as we grow older, our brain's ability to remove toxic buildup slows down. However, new research in mice demonstrates that it’s possible to reverse age-related effects and restore the brain’s waste-clearing process.
“This research shows that restoring cervical lymph vessel function can substantially rescue the slower removal of waste from the brain associated with age,” said Douglas Kelley, PhD, a professor of Mechanical ...
Zebrafish use surprising strategy to regrow spinal cord
2024-08-15
Zebrafish are members of a rarefied group of vertebrates capable of fully healing a severed spinal cord. A clear understanding of how this regeneration takes place could provide clues toward strategies for healing spinal cord injuries in people. Such injuries can be devastating, causing permanent loss of sensation and movement.
A new study from Washington University School of Medicine in St. Louis maps out a detailed atlas of all the cells involved — and how they work together — in regenerating the zebrafish spinal cord. In an unexpected finding, the researchers showed that survival and adaptability of the severed neurons themselves is required for full spinal cord regeneration. ...
Bone fracture rates vary dramatically by race
2024-08-15
A new paper in the Journal of Bone and Mineral Research, published by Oxford University Press, finds that bone fracture rates in older women differ by race, quite significantly. While researchers have known for years that the risk of bone fracture is highest for White women, this is the first study to show the real fracture rate for Asian and Hispanic women.
Until recently researchers have had limited data on fracture rates by specific race and ethnicity beyond White people, and even less fracture data within race and ethnic groups. Hispanic and Asian populations are the ...
2024 Shanghai Ranking: Hebrew University rises to 81st, showcasing academic excellence
2024-08-15
For the second consecutive year, three Israeli universities are ranked among the top 100 institutions globally. Alongside the Hebrew University, ranked 81st, are the Technion (85th) and the Weizmann Institute (69th). This is an outstanding achievement for Israeli academia and especially for the Hebrew University.
Professor Asher Cohen, President of the Hebrew University, stated: "The presence of three Israeli universities in the list of the top 100 universities globally is an exceptional achievement in such a challenging and complex year. The Hebrew University's rise to 81st place ...
Neoadjuvant immunotherapy may facilitate surgery and improve outcomes for patients with high-risk liver cancer
2024-08-15
Bottom Line: Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not have been eligible for surgery by conventional criteria—had similar outcomes to patients who received surgery upfront, according to results from a retrospective study.
Journal in Which the Study was Published: Cancer Research Communications, a journal of the American Association for Cancer Research (AACR)
Author: Mari Nakazawa, MD, first author of the study and a clinical research fellow ...
Racial, economic barriers hinder access to medicine for treating opioid use disorder
2024-08-15
PORTLAND, Ore. – Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community that’s racially and economically segregated, according to a new study led by scientists at Oregon State University and Johns Hopkins University.
The findings shed additional light on inequities in health care as the U.S.’s overdose crisis continues to accelerate, with fatality rates rising fastest in Black and Hispanic/Latinx communities.
“While there have been notable policy changes over the past decade that ...
Weather and geography drive waterborne infectious disease outbreaks
2024-08-15
An analysis of 12 years of data collected from over 500 hospitals in 25 different U.S. states shows that weather, geographic location, and urban or rural location all appear to influence hospitalizations for waterborne infectious diseases, according to a new study by researchers at Columbia University in the open-access journal PLOS Water.
Waterborne infectious diseases caused by bacteria, parasites, and viruses still affect over 7,000,000 people annually in the United States despite drinking and recreational water regulations, and sanitation ...
First-of-its-kind vaccine expands malaria protection for pregnant women
2024-08-15
August 14, 2024 – In a report published in The Lancet Infectious Diseases (Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials) a team led by investigators at the Malaria Research and Training Center (MRTC), Bamako, Mali; the Laboratory of Malaria Immunology and Vaccinology (LMIV), National Institute of Allergy and Infectious Diseases, National Institutes of Health; and Sanaria Inc. describes ...
Candidate malaria vaccine provides lasting protection in NIH-sponsored trials
2024-08-15
WHAT:
Two National Institutes of Health (NIH)-supported trials of an experimental malaria vaccine in healthy Malian adults found that all three tested regimens were safe. One of the trials enrolled 300 healthy women ages 18 to 38 years who anticipated becoming pregnant soon after immunization. That trial began with drug treatment to remove malaria parasites, followed by three injections spaced over a month of either saline placebo or the investigational vaccine at one of two dosages. Both dosages of the vaccine candidate conferred a significant degree of protection from parasite infection and clinical malaria that was sustained ...
Pioneering research sheds light on how babies and young children understand the art of pretence
2024-08-15
Babies recognise pretence and around half of children can pretend themselves by 12 months, new research has found.
The study, led by the University of Bristol, shows for the first time how children’s awareness and grasp of pretence in its various forms develops from birth to three years.
Lead author Prof Elena Hoicka, Professor of Psychology in Education at the University’s School of Education, said: “Our findings highlight how pretending is a complex, evolving process which begins very early on in life, helping their cognitive and social skills to advance. Pretence ...